• People
  • Practices
  • Insights
    • Firm News
    • Press Releases
    • Publications
    • Webcasts
    • Podcasts
    • Subscribe
    • Media Contacts
  • Careers
    • Career Opportunities
    • Attorney Development
    • Contact Us
  • About
    • Our Story
    • Awards & Accolades
    • Offices
    • Diversity
    • Pro Bono
    • Alumni
    • Contact Us
  • Search
  • Biography
  • Education
  • Recent Publications
Profile Picture

Andrew Philip Blythe

Andrew
Blythe

Associate Attorney

CONTACT INFO

ablythe@gibsondunn.com

TEL:+1 949.451.3926

FAX:+1 949.475.4630

Orange County

3161 Michelson Drive, Suite 1200, Irvine, CA 92612-4412 USA

  • Print
  • |
  • Share
  • |
  • vCard

PRACTICE

Intellectual Property Life Sciences Litigation Media, Entertainment and Technology

BIOGRAPHY

Andrew Blythe is a litigation associate in the Orange County office of Gibson, Dunn & Crutcher. He practices in Gibson Dunn’s Intellectual Property Practice Group, with a focus on patent litigation. Andrew has substantive litigation experience from complaint through appeal, including trials both in district court and before the United States Patent and Trademark Office.

Representative Matters

  • Lead associate representing global pharmaceutical company as defendant in patent litigation accusing company’s medical devices of infringement.
  • Successfully defended leading networking company in multi-patent infringement action, resulting in directed verdict in company’s favor at close of plaintiff’s case during jury trial.
  • Obtained early summary judgment of noninfringement on behalf of global consumer products company in multi-patent case.
  • Represented global pharmaceutical company as petitioner in four related IPR proceedings before the Patent Trials and Appeals Board of the USPTO.  Argued disputed motions before the Board and served as second-chair for Oral Hearing.
  • Obtained preliminary injunction and final judgement following bench trial on behalf of global pharmaceutical company as patent owner in Hatch-Waxman litigation against more than 20 generic pharmaceutical manufacturers.
  • Successfully defended pharmaceutical patent from IPR challenges brought by three petitioners before the Patent Trials and Appeals Board of the USPTO.
  • Represented plaintiff global pharmaceutical company in Hatch-Waxman litigation resulting in defendants’ cancellation of trial and final judgment in company’s favor.
  • Member of trial team that obtained multi-million-dollar jury verdict for leading data storage company in patent infringement trial.

Andrew earned his Juris Doctor, cum laude, from Harvard Law School. He earned his Bachelor of Arts degree, summa cum laude, in mathematical economics with a minor in physics from Occidental College where he was elected to Phi Beta Kappa.

Andrew is admitted to practice in the States of California and New York and as a registered patent attorney before the United States Patent and Trademark Office.

 

EDUCATION

Harvard University - 2015 Juris Doctor

Occidental College - 2009 Bachelor of Arts

ADMISSIONS

California Bar

New York Bar

RECENT PUBLICATIONS

Client Alert - April 20, 2021 | Aerospace and Related Technologies Update – Spring 2021
Publications - February 5, 2021 | New Drone Rules Show FAA is Listening to the Industry
Client Alert - February 21, 2019 | Media, Entertainment and Technology Group Outlook and Review – 2019
Client Alert - August 8, 2018 | Media, Entertainment and Technology Group – 2018 Mid-Year Update
Client Alert - January 19, 2018 | Media, Entertainment and Technology Group – 2017 Year-End Update
  • Sitemap
  • Client Extranet
  • Terms of Use and Legal Notices
  • Privacy Statement
  • Cookie Notice
  • Contact Us
© 2023 Gibson, Dunn & Crutcher LLP.  All rights reserved.  For contact and other information, please visit us at gibsondunn.com.
Top
Gibson Dunn uses cookies which are essential for our website to function. With your consent, we and third parties may also use non-essential cookies to collect information about your browsing activities, and improve the content, functionality and performance of our website. By clicking “Accept All”, you consent to the use of all cookies on our website as set out in our Cookie Notice. You can reject all non-essential cookies by clicking “Reject All”. Choose "Manage Cookies" to view and customize your cookie settings.
Manage CookiesACCEPT ALLREJECT ALL
Manage consent

Your Privacy Choices / Cookies

This website uses cookies – small text files stored on your device, when you visit a website - including third party cookies to collect information about your browsing activities and improve the content, functionality and performance of our website. Out of these cookies, the cookies that are categorized as Necessary Cookies are stored on your browser as they are essential for the operation of the website. You may accept all cookies, or reject all cookies other than Necessary Cookies.  If you visit us from a different device or browser, or clear cookies, then you may need to return to this screen to re-select your preferences.   Note that rejecting some of these cookies may have an effect on your browsing experience. Please note that if you do not make a selection below, only necessary cookies will be set.

You can learn more about our processing of your personal data by visiting our Privacy Policy.
Necessary
Always Enabled
Necessary cookies are essential for our website to function and cannot be switched off in our systems. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms. Without these cookies, our website will not operate properly.   Cookie Details
Analytics
These cookies are used to collect information on how you use our website, including information about the pages you visited, how long you visited and if you experienced any errors. We use this information to help us improve the quality of our website and monitor the level of activity on our website. They may be set by third parties whose services have been added to our pages. Cookie Details
Save & Accept